This is a working overview of Melanotan II, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-06-08 and is reviewed periodically as new material appears.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analogue of alpha-melanocyte-stimulating hormone |
| Common synonyms | MT-II; melanotan 2 | No internationally accepted non-proprietary name |
| Typical presentation | Lyophilised powder in a sealed vial | Often supplied alongside a separate diluent |
| Regulatory status | Unapproved therapeutic substance | Customs seizure reported in several jurisdictions |
| Reported route in use | Subcutaneous injection | Self-administered outside clinical settings |
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Following Maduro's capture, demonstrations celebrating his removal and opposing his presidency occurred in Caracas, the capital and largest city of Venezuela. Venezuelans living abroad celebrated Maduro's removal across the United States, Spain, and Latin America. In Doral, Florida, where the largest population of Venezuelans in the US live, Venezuelans filled the streets waving flags, singing, and chanting "freedom". Thousands of Venezuelans celebrated Maduro's fall in Madrid, Spain. Videos from the Colombian border city of Cúcuta showed crowds filling the streets on the night of 3 January 2026, dancing to music and chanting slogans like "virtue" and "a free Venezuela". Similar celebrations by Venezuelan expatriates and refugees took place in Buenos Aires in Argentina, Lima in Peru, Quito in Ecuador, and Santiago in Chile.
C6H12O6 → 3 CH4 + 3 CO2 These hydrocarbon deposits, collected in porous rocks trapped beneath impermeable cap rocks, comprise commercial oil fields. They have formed over millions of years and once exhausted cannot be readily replaced. The depletion of these hydrocarbons reserves is the basis for what is known as the energy crisis. Alkanes have a low solubility in water, so the content in the oceans is negligible; however, at high pressures and low temperatures (such as at the bottom of the oceans), methane can co-crystallize with water to form a solid methane clathrate (methane hydrate). Although this cannot be commercially exploited at the present time, the amount of combustible energy of the known methane clathrate fields exceeds the energy content of all the natural gas and oil deposits put together. Methane extracted from methane clathrate is, therefore, a candidate for future fuels.
. Moreover population dynamics like birth and death processes can be included. Such complex models enable a deeper understanding of infection dynamics and the introduction of different pharmaceutical and non-pharmaceutical interventions.
Sources: en.wikipedia.org
=== 3T Biosciences === The startup develops T-Cell therapy, which strengthens the immune system to fight cancer cells. The company relies on Garcia's research. Business operations are led by Luke Lee, a PhD student in cancer biology. The company’s principal investor is Asset Management Ventures, with additional involvement from a group of academics from Christopher Garcia’s biology lab at Stanford University, according to CNBC. Other known founders are Gee Marvin and Lee Sibener. The startup has a partnership with Boehringer Ingelheim. Most microsatellite stable colorectal cancers (MSS CRC) resist checkpoint inhibitors, like many other "cold" tumors. 3T Biosciences’ 3T-TRACE platform uses diverse target libraries and machine learning to find new shared TCR targets beyond the limits of traditional proteome-based methods.
Lastly, antibodies against components of the thyroid, particularly anti-TPO and anti-thyroglobulin, can be measured. These may be present in normal individuals but are highly sensitive for autoimmune-related disease.
Otto Hahn (German: [ˈɔtoː ˈhaːn] ; 8 March 1879 – 28 July 1968) was a German chemist who was a pioneer in the field of radiochemistry. He is referred to as the father of nuclear chemistry and discoverer of nuclear fission, the science behind nuclear reactors and nuclear weapons. Hahn and Lise Meitner discovered isotopes of the radioactive elements radium, thorium, protactinium and uranium. He also discovered the phenomena of atomic recoil and nuclear isomerism, and pioneered rubidium–strontium dating. In 1938, Hahn, Meitner and Fritz Strassmann discovered nuclear fission, for which Hahn alone was awarded the 1944 Nobel Prize in Chemistry. A graduate of Marburg University, which awarded him a doctorate in 1901, Hahn studied under Sir William Ramsay at University College London and at McGill University in Montreal, Canada, under Ernest Rutherford, where he discovered several new radioactive isotopes. He returned to Germany in 1906; Emil Fischer let him use a former woodworking shop in the basement of the Chemical Institute at the Friedrich Wilhelm University of Berlin as a laboratory. Hahn completed his habilitation in early 1907 and became a Privatdozent. In 1912, he became head of the Radioactivity Department of the newly founded Kaiser Wilhelm Institute for Chemistry (KWIC). Working with Austrian physicist Lise Meitner in the building that now bears their names, they made a series of groundbreaking discoveries, culminating with her isolation of the longest-lived isotope of protactinium in 1918.
Sources: en.wikipedia.org
==== Alzheimer's disease ==== There is indirect evidence to suggest that system Xc- might be upregulated in Alzheimer's patients. It has been found in Alzheimer's patients that there is an increase in phosphorylation of the alpha subunit of eukaryotic initiation factor 2 and in expression of transcription factor 4, both of which increase system Xc- expression. It has also been shown that administration of N-acetylcysteine leads to a significant improvement in certain cognitive tasks for Alzheimer's patients.
Boodikka appears in Green Lantern: First Flight, voiced by Tricia Helfer. This version is an ally of Sinestro who is later killed in a fight with Hal Jordan and Kilowog. Boodikka makes a cameo appearance in Green Lantern: Emerald Knights, voiced again by Grey DeLisle. Boodikka makes a cameo appearance in Green Lantern (2011).
Bowfin eggs are adhesive, and attach to aquatic vegetation, roots, gravel, and sand. After hatching, larval bowfin do not swim actively in search of food. During the 7-9 days required for yolk-sac absorption, they attach to vegetation by means of an adhesive organ on their snout, and remain protected by the parent male bowfin. Bowfin aggressively protect their spawn from the first day of incubation to a month or so after the eggs have hatched. When the fry are able to swim and forage on their own, they form a school and leave the nest accompanied by the parent male bowfin, which slowly circles them to prevent separation. Bowfin reach sexually maturity at 2-3 years of age. They can live up to 30 years in captivity.
=== Hoogsteen base pairing === A thymine (T) nucleobase can bind to a Watson–Crick base-pairing of T-A by forming a Hoogsteen hydrogen bond. The thymine hydrogen bonds with the adenosine (A) of the original double-stranded DNA to create a T-A*T base-triplet.
Sources: en.wikipedia.org
No. No major regulatory agency has granted a marketing authorisation for melanotan II as a medicine. Products sold under this name are generally presented as laboratory reagents and are not subject to the batch-release testing applied to approved drugs.
It was developed in the 1980s by researchers investigating analogues of alpha-melanocyte-stimulating hormone for pigmentation and related endpoints. Early work included small human studies during the 1990s. Development did not progress to licensing, and the compound remained a research and grey-market item.
Peptides are prone to truncation, oxidation and aggregation during synthesis and handling. Without independent testing, a buyer cannot confirm the identity or the content of a vial. Analytical surveys of unapproved peptide products have repeatedly found discrepancies between label claims and measured composition.
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.